Gene modification strategies for next-generation CAR T cells against solid cancers
Abstract Immunotherapies have become the backbone of cancer treatment. Among them, chimeric antigen receptor (CAR) T cells have demonstrated great success in the treatment of hematological malignancies. However, CAR T therapy against solid tumors is less effective. Antigen targeting; an immunosuppre...
Main Authors: | Yonggui Tian, Yilu Li, Yupei Shao, Yi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00890-6 |
Similar Items
-
Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors
by: Christopher DeRenzo, et al.
Published: (2019-02-01) -
CAR-macrophage: A new immunotherapy candidate against solid tumors
by: Yizhao Chen, et al.
Published: (2021-07-01) -
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
by: Benedetto Sacchetti, et al.
Published: (2019-04-01) -
Making CAR T Cells a Solid Option for Solid Tumors
by: Andrea Schmidts, et al.
Published: (2018-11-01) -
Innovative CAT-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
by: Yuna Jo, et al.
Published: (2020-07-01)